We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




IgG Assays Determine Serological Status to Measles/ Mumps Viruses

By LabMedica International staff writers
Posted on 09 Aug 2011
Two new assays were developed for the semi-quantitative determination of antibodies to measles and mumps viruses.

The Liaison Measles Immunoglobulin G (IgG) and Liaison Mumps IgG assays use chemiluminescence immunoassay technology on the Liaison analyzer for the semiquantitative determination of IgG antibodies to measles and mumps viruses in human serum or plasma.

The introduction of these assays by DiaSorin (Vercelli, Italy) completes the company's Liaison Measles, Mumps, Rubella, and Varicella Zoster (MMRV) IgG panel of assays, which are performed on a single platform. More...
DiaSorin’s Liaison IgG assays are fully automated semiquantitative or quantitative serology assays, each having a time-to-first result of 35 minutes and a throughput of 90 results per hour.

The Liaison analyzer combines a flexible operating mode with a broad assay menu and is very efficient due to its long walk-away time. The possibility to run up to 15 different assays at a time provides everyday testing even for low numbers of samples. A throughput of up to 180 determinations per hour allows the instrument to cope easily with a large number of samples. It is easy to use due to its touch-screen monitor, clear software structure, and the Reagent Integral, which contains all assay-specific reagents.

Related Links:

DiaSorin





Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.